Host virus interactions and the molecular regulation of HIV-1: role in the pathogenesis of HIV-associated nephropathy (Q45782813)

16 December 2017

editorial

0 references

review article

1 reference

title

Host virus interactions and the molecular regulation of HIV-1: role in the pathogenesis of HIV-associated nephropathy (English)

1 reference

16 December 2017

0 references

2

1 reference

16 December 2017

author name string

Rappaport J

series ordinal

1

1 reference

16 December 2017

Klotman PE

series ordinal

3

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

16 December 2017

published in

Kidney International

1 reference

16 December 2017

volume

46

1 reference

16 December 2017

issue

1

1 reference

16 December 2017

page(s)

16-27

1 reference

16 December 2017

https://api.crossref.org/works/10.1038%2FKI.1994.240

1 reference

7 January 2021

Renal involvement in patients infected with HIV: experience at San Francisco General Hospital

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Increasing incidence of human immunodeficiency virus-associated nephropathy at San Francisco General Hospital

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Renal disease in children with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Nephrotic syndrome associated with acquired immunodeficiency syndrome in children.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Mycoplasma fermentans (incognitus strain) infection in the kidneys of patients with acquired immunodeficiency syndrome and associated nephropathy: a light microscopic, immunohistochemical, and ultrastructural study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Crescentic IgA nephropathy as a manifestation of human immune deficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Absence of HIV antigens in renal tissue from patients with HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Human Mesangial Cells Are Resistant to Productive Infection by Multiple Strains of Human Immunodeficiency Virus Types 1 and 2

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV-associated nephropathy in transgenic mice expressing HIV-1 genes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Lymphocyte activation by HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Regulatory genes of human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The biochemistry of AIDS.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

A second post-transcriptional trans-activator gene required for HTLV-III replication

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Transcriptional activation of homologous viral long terminal repeats by the human immunodeficiency virus type 1 or the human T-cell leukemia virus type I tat proteins occurs in the absence of de novo protein synthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV TAR: an RNA enhancer?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Conformation of the TAR RNA-Arginine Complex by NMR Spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Fingering too many proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Functional substitution of the basic domain of the HIV-1 trans-activator, Tat, with the basic domain of the functionally heterologous Rev

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Role of RNA structure in arginine recognition of TAR RNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Trans-activation by HIV-1 Tat via a heterologous RNA binding protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Direct interaction of human TFIID with the HIV-1 transactivator tat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Cellular uptake of the tat protein from human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The absence of Tat sequences in tissues of HIV-negative patients with epidemic Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Effects of HIV-1 Tat protein on human T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Transforming growth factor-beta: recent progress and new challenges

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV-1 infection of human T lymphocytes results in enhanced alpha 5 beta 1 integrin expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Secondary structure is the major determinant for interaction of HIV rev protein with RNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Recognition of the high affinity binding site in rev-response element RNA by the Human Immunodeficiency Virus type-1 rev protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Evidence for a direct interaction of Rev protein with nuclear envelop mRNA-translocation system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The HIV-1 nef gene product is associated with phosphorylation of a 46 kD cellular protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Human immunodeficiency virus type 1 negative factor is a transcriptional silencer

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Differential effects of nef on HIV replication: implications for viral pathogenesis in the host

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Serine phosphorylation-independent downregulation of cell-surface CD4 by nef

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is rev-dependent and regulated by splicing

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Induction of cell differentiation by human immunodeficiency virus 1 vpr.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Human immunodeficiency virus vpr gene encodes a virion-associated protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Identification of a protein encoded by the vpu gene of HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

A novel gene of HIV-1, vpu, and its 16-kilodalton product

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Functional role of human immunodeficiency virus type 1 vpu.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Human immunodeficiency virus type 1vif, vpr, andvpu mutants can produce persistently infected cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Expression of nef, vpu, CA and CD4 during the infection of lymphoid and monocytic cell lines with HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The sor gene of HIV-1 is required for efficient virus transmission in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

The HIV 'A' (sor) gene product is essential for virus infectivity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Cell-free transmission of Vif mutants of HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Intermediate filament assembly and stability in vitro: effect and implications of the removal of head and tail domains of vimentin by the human immunodeficiency virus type 1 protease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Non-viral cellular substrates for human immunodeficiency virus type 1 protease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Cleavage of the Intermediate Filament Subunit Protein Vimentin by HIV-1 Protease: Utilization of a Novel Cleavage Site and Identification of Higher Order Polymers of Pepstatin A

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Potential role of the viral protease in human immunodeficiency virus type 1 associated pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.240

7 January 2021

Identifiers

DOI

10.1038/KI.1994.240

1 reference

16 December 2017

Dimensions Publication ID

1041987338

0 references

1 reference

16 December 2017